MERCK KGAA O.N./ DE0006599905 /
4/26/2024 9:57:38 PM | Chg. +2.750 | Volume | Bid9:59:51 PM | Ask9:59:51 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
152.750EUR | +1.83% | 4,735 Turnover: 717,508.400 |
151.600Bid Size: 100 | 153.200Ask Size: 100 | 19.63 bill.EUR | 1.45% | 23.41 |
GlobeNewswire
3/4
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
12/21/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
12/14/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
10/17/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA